181 related articles for article (PubMed ID: 27863652)
21. Targeted lipoplexes for siRNA delivery.
Cardoso A; Trabulo S; Moreira JN; Düzgüneş N; de Lima MC
Methods Enzymol; 2009; 465():267-87. PubMed ID: 19913172
[TBL] [Abstract][Full Text] [Related]
22. Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes.
Schlegel A; Largeau C; Bigey P; Bessodes M; Lebozec K; Scherman D; Escriou V
J Control Release; 2011 Jun; 152(3):393-401. PubMed ID: 21497175
[TBL] [Abstract][Full Text] [Related]
23. Systemic delivery of siRNA by hyaluronan-functionalized calcium phosphate nanoparticles for tumor-targeted therapy.
Qiu C; Wei W; Sun J; Zhang HT; Ding JS; Wang JC; Zhang Q
Nanoscale; 2016 Jul; 8(26):13033-44. PubMed ID: 27314204
[TBL] [Abstract][Full Text] [Related]
24. In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles.
Ganesh S; Iyer AK; Gattacceca F; Morrissey DV; Amiji MM
J Control Release; 2013 Dec; 172(3):699-706. PubMed ID: 24161254
[TBL] [Abstract][Full Text] [Related]
25. Enhanced transfection rates of small-interfering RNA using dioleylglutamide-based magnetic lipoplexes.
Lee S; Shim G; Kim S; Kim YB; Kim CW; Byun Y; Oh YK
Nucleic Acid Ther; 2011 Jun; 21(3):165-72. PubMed ID: 21749293
[TBL] [Abstract][Full Text] [Related]
26. Reduced in vitro and in vivo toxicity of siRNA-lipoplexes with addition of polyglutamate.
Schlegel A; Bigey P; Dhotel H; Scherman D; Escriou V
J Control Release; 2013 Jan; 165(1):1-8. PubMed ID: 23123257
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
[TBL] [Abstract][Full Text] [Related]
28. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
[TBL] [Abstract][Full Text] [Related]
29. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy.
Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Fu H; Zhang Z; He Q
J Pharm Sci; 2015 Feb; 104(2):476-84. PubMed ID: 25256603
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of defined oligohyaluronates-decorated liposomes and interaction with lung cancer cells.
Cano ME; Lesur D; Bincoletto V; Gazzano E; Stella B; Riganti C; Arpicco S; Kovensky J
Carbohydr Polym; 2020 Nov; 248():116798. PubMed ID: 32919536
[TBL] [Abstract][Full Text] [Related]
31. PEGylated and non-PEGylated siRNA lipoplexes formulated with cholesteryl cytofectins promote efficient luciferase knockdown in HeLa tat luc cells.
Daniels A; Singh M; Ariatti M
Nucleosides Nucleotides Nucleic Acids; 2013; 32(4):206-20. PubMed ID: 24001194
[TBL] [Abstract][Full Text] [Related]
32. Cell Permeable NBD Peptide-Modified Liposomes by Hyaluronic Acid Coating for the Synergistic Targeted Therapy of Metastatic Inflammatory Breast Cancer.
Sun Y; Li X; Zhang L; Liu X; Jiang B; Long Z; Jiang Y
Mol Pharm; 2019 Mar; 16(3):1140-1155. PubMed ID: 30668131
[TBL] [Abstract][Full Text] [Related]
33. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.
Qhattal HS; Hye T; Alali A; Liu X
ACS Nano; 2014 Jun; 8(6):5423-40. PubMed ID: 24806526
[TBL] [Abstract][Full Text] [Related]
34. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.
Jiang G; Park K; Kim J; Kim KS; Hahn SK
Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144
[TBL] [Abstract][Full Text] [Related]
35. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
[TBL] [Abstract][Full Text] [Related]
36. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes.
Choi KM; Jang M; Kim JH; Ahn HJ
Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA.
Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S
Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronic Acid-Decorated Liposomes as Innovative Targeted Delivery System for Lung Fibrotic Cells.
Pandolfi L; Frangipane V; Bocca C; Marengo A; Tarro Genta E; Bozzini S; Morosini M; D'Amato M; Vitulo S; Monti M; Comolli G; Scupoli MT; Fattal E; Arpicco S; Meloni F
Molecules; 2019 Sep; 24(18):. PubMed ID: 31509965
[TBL] [Abstract][Full Text] [Related]
39. Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides.
Han SE; Kang H; Shim GY; Kim SJ; Choi HG; Kim J; Hahn SK; Oh YK
J Drug Target; 2009 Feb; 17(2):123-32. PubMed ID: 19012052
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
